A Frailty Assessment Tool to Predict In-Hospital Mortality in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

References

• Woodruff PG, Agusti A, Roche N, Singh D, Martinez FJ. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet. 2015;385(9979):1789–1798. doi:10.1016/S0140-6736(15)60693-6
   PubMed Web of Science ®Google Scholar
• Tamer A, Baess AI, Monsif DAA, Elnasharty AAA. Role of C-reactive protein and interleukin-6 in predicting the prognosis of ICU-admitted patients with acute exacerbation of COPD. Egypt J Chest Dis Tuberculosis. 2014;63(4):829–835. doi:10.1016/j.ejcdt.2014.06.003
   Google Scholar
• Duman D, Aksoy E, Agca MC, et al. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia. Int J Chron Obstruct Pulmon Dis. 2015;10:2469–2478. doi:10.2147/COPD.S90330
   PubMed Web of Science ®Google Scholar
• Leuzzi G, Galeone C, Taverna F, Suatoni P, Morelli D, Pastorino U. C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis. Eur Respir Rev. 2017;26(143):160070. doi:10.1183/16000617.0070-2016
   PubMed Web of Science ®Google Scholar
• Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–976. doi:10.1136/thoraxjnl-2012-202103
   PubMed Web of Science ®Google Scholar
• Memon MA, Faryal S, Brohi N, Kumar B. Role of the DECAF score in predicting in-hospital mortality in acute exacerbation of chronic obstructive pulmonary disease. Cureus. 2019;11(6):e4826. doi:10.7759/cureus.4826
   PubMed Web of Science ®Google Scholar
• Surapaneni KP. S, N S. DECAF score for assessing prognosis in Acute Exacerbation of COPD. J Assoc Physicians India. 2020;68(1):82.
   PubMedGoogle Scholar
• Rahimirad S, Ghafari M, Ansarin K, Rashidi F, Rahimi-Rad MH. Elevated red blood cell distribution width predicts mortality in acute exacerbation of COPD. Pneumologia. 2016;65(2):85–89.
   PubMedGoogle Scholar
• Epstein D, Nasser R, Mashiach T, Azzam ZS, Berger G. Increased red cell distribution width: a novel predictor of adverse outcome in patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease. Respir Med. 2018;136:1–7. doi:10.1016/j.rmed.2018.01.011
   PubMed Web of Science ®Google Scholar
• Wu CW, Lan CC, Hsieh PC, Tzeng IS, Wu YK. Role of peripheral eosinophilia in acute exacerbation of chronic obstructive pulmonary disease. World J Clin Cases. 2020;8(13):2727–2737. doi:10.12998/wjcc.v8.i13.2727
   PubMed Web of Science ®Google Scholar
• Yao C, Liu X, Tang Z. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2285–2290. doi:10.2147/COPD.S141760
   PubMed Web of Science ®Google Scholar
• Huang Q, He C, Xiong H, et al. DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMJ Open. 2020;10(10):e037923. doi:10.1136/bmjopen-2020-037923
   PubMed Web of Science ®Google Scholar
• Rockwood K, et al. A global clinical measure of fitness and frailty in elderly people. Cmaj Canadian Medical Association Journal. 2005;173(5):489–495. doi:10.1503/cmaj.050051
   PubMed Web of Science ®Google Scholar
• Kizilarslanoglu MC, Civelek R, Kilic MK, et al. Is frailty a prognostic factor for critically ill elderly patients. Aging Clin Exp Res. 2017;29(2):1–9.
   Web of Science ®Google Scholar
• Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14(6):392–397. doi:10.1016/j.jamda.2013.03.022
   PubMed Web of Science ®Google Scholar
• Fragoso CAV, Enright PL, McAvay G, Van Ness PH, Gill TM. Frailty and respiratory impairment in older persons. Am J Med. 2012;125(1):1–86.
   PubMed Web of Science ®Google Scholar
• Limpawattana P, Putraveephong S, Inthasuwan P, Boonsawat W, Theerakulpisut D, Chindaprasirt J. Frailty syndrome in ambulatory patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:1193–1198. doi:10.2147/COPD.S134233
   PubMed Web of Science ®Google Scholar
• Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24. doi:10.1186/1471-2318-8-24
   PubMedGoogle Scholar
• Rockwood K, McMillan M, Mitnitski A, Howlett SE, Frailty Index A. Based on common laboratory tests in comparison with a clinical frailty index for older adults in long-term care facilities. J Am Med Dir Assoc. 2015;16(10):842–847. doi:10.1016/j.jamda.2015.03.027
   PubMed Web of Science ®Google Scholar
• Howlett SE, Rockwood MR, Mitnitski A, Rockwood K. Standard laboratory tests to identify older adults at increased risk of death. BMC Med. 2014;12(1):171. doi:10.1186/s12916-014-0171-9
   PubMedGoogle Scholar
• Yang M, Zhuo Y, Hu X, Xie L. Predictive validity of two frailty tools for mortality in Chinese nursing home residents: frailty index based on common laboratory tests (FI-Lab) versus FRAIL-NH. Aging Clin Exp Res. 2018;30(12):1445–1452. doi:10.1007/s40520-018-1041-7
   PubMed Web of Science ®Google Scholar
• Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41–55. doi:10.1093/biomet/70.1.41
   Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Respirology. 2017;22(3):575–601.
   PubMed Web of Science ®Google Scholar
• Mcshane LM, Altman DG, Willi S. Identification of clinically useful cancer prognostic factors: what are we missing. J Natl Cancer Inst. 2005;97(14):1023–1025. doi:10.1093/jnci/dji193
   PubMedGoogle Scholar
• Gruttola VGD, Clax P, Demets DL, et al. Considerations in the evaluation of surrogate endpoints in clinical trials: summary of a national institutes of health workshop. J Natl Cancer Inst. 2001;22(5):485–502.
   Google Scholar
• DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845. doi:10.2307/2531595
   PubMed Web of Science ®Google Scholar
• Gu Y. [Biomarker in acute exacerbation of chronic obstructive pulmonary disease]. Zhonghua Jie He Hu Xi Za Zhi. 2014;37(4):247–249. Chinese.
   PubMedGoogle Scholar
• Nafae R, Embarak S, Gad DM. Value of the DECAF score in predicting hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease admitted to Zagazig University Hospitals, Egypt. Egypt J Chest Dis Tuberculosis. 2015;64(1):35–40. doi:10.1016/j.ejcdt.2014.10.007
   Google Scholar
• Sangwan V, Chaudhry D, Malik R. Dyspnea, eosinopenia, consolidation, acidemia and atrial fibrillation score and BAP-65 score, tools for prediction of mortality in acute exacerbations of chronic obstructive pulmonary disease: a comparative pilot study. Indian J Crit Care Med. 2017;21(10):671–677. doi:10.4103/ijccm.IJCCM_148_17
   PubMedGoogle Scholar
• Gale NS, Albarrati AM, Munnery MM, et al. Frailty: a global measure of the multisystem impact of COPD. Chron Respir Dis. 2018;15(4):347–355. doi:10.1177/1479972317752763
   PubMed Web of Science ®Google Scholar
• Bernabeu-Mora R, Oliveira-Sousa SL, Piedad Sánchez-Martínez M, et al. Frailty transitions and associated clinical outcomes in patients with stable COPD: a longitudinal study. PLoS One. 2020;15(4):e0230116. doi:10.1371/journal.pone.0230116
   PubMed Web of Science ®Google Scholar
• Blodgett JM, Theou O, Howlett SE, Wu FCW, Rockwood K. A frailty index based on laboratory deficits in community-dwelling men predicted their risk of adverse health outcomes. Age Ageing. 2016;45(4):afw054. doi:10.1093/ageing/afw054
   Web of Science ®Google Scholar